Effects of weight-reduction on obesity-associated diseases by Liebermeister, Hermann
Effectsofweight-reductiononobesity-associateddiseases
Auswirkungen einer Gewichtsreduktion auf Adipositas-assoziierte
Krankheiten
Abstract
Even moderate, but persistent weight-loss ameliorates most of the re-
lated diseases in obesity. Besides the consequences of the metabolic
HermannLiebermeister
1
syndrome, this includes less well-known obesity-associated changes,
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such as impaired fertility, menstrual disorders, psychic changes, total
leucocyte-countasaparameterofimmunityandtheimpairedpulmonary
function in asthma and sleep-apnoea.
Life-expectancy is prolonged by diminution of visceral fat depots, whilst
weight-lossbyshrinkingoffat-freebody-massseemstohaveacontrary
effect.
Zusammenfassung
Auch eine mäßige, aber dauerhafte Gewichtsverringerung bessert die
meisten Begleitkrankheiten der Adipositas. Dazu gehören - neben dem
Metabolischen Syndrom - auch weniger bekannte Folgeerscheinungen
der Adipositas, wie Fertilitätsstörungen, Menstruations-Anomalien,
psychische Veränderungen, die Gesamt-Leukozyten-Konzentration als
Parameter für die Immunitäts-Lage und die gestörte Lungenfunktion
bei Asthma und Schlaf-Apnöe.
Die Lebenserwartung erhöht sich nach Verringerung der intraabdomi-
nalen Fett-Depots, während ein Gewichtsverlust infolge Abbaus der
fettfreien Körpermasse den gegenteiligen Effekt auszulösen scheint.
Text
A meta-analysis of 23 studies on 599 volunteers [1] has
shown that - independently of the procedure chosen -
visceral fat is diminished more effectively than total fat.
Thus the potentially dangerous visceral fat responds es-
pecially well to weight reduction.
We therefore may expect that weight reduction has a fa-
vorable effect on obesity-associated diseases.
It is well known that more than 80 % of non-insulin-de-
pendent diabetics are overweight. S.D. Müller from
Aachen has put it this way: "Type-2-diabetics don't have
diabetes, but a belly." He is getting nearer to the truth,
asthestarvation-periodsduringandafterbothworld-wars
lowereddiabetes-mortalitymuchmorethantheintroduc-
tion of insulin or of oral anti-diabetic medication.
Moreover, weight reduction leads - as has been well
known for many years [2] - to a clear-cut reduction of el-
evated serum-levels of glucose, triglycerides and insulin.
This metabolic improvement and the normalization of
insulin-incretion with a pronounced early phase and
moderatelong-termincretionpersistonlyhoweverifthere
is no substantial regain in weight [3].
Many diabetics can - depending on the degree of their
weight-loss- reduceorabandontheirmedication:insulin
ororalanti-diabeticsandlimitthemselvestopurelydietet-
ic measures [4].
Pronouncedweight-lossaftersurgicaltreatmentofobesity
III has dramatic effects as shown by the 2 years follow-
up of the Scandinavian Obesity Study (SOS) [5].
The diabetes incidence in the surgically operated group
is therefore 16 times lower than in the conventionally
treated group. Even ten years after the surgical interven-
tion, diabetes-risk is still 3,4 times lower [6].
A moderate weight-loss not only improves the diabetic
metabolism,butalsoamelioratesotherrisk-factorsinher-
ent to the metabolic syndrome [7]:
A meta-analysis of 14 studies has shown that a weight
reduction by 10 % - (= ca. 10 kg) - leads to a lowering of
the accompanying hypertension. A weight loss of 10 kg
diminishes systolic blood-pressure by approximately 15
mmHg, the diastolic pressure by about 10 mmHg [8].
Another meta-analysis of 16 controlled studies by the
Cochrane Collaboration demonstrated in every one of
themthatweight-reductionwassignificantlymoreeffect-
ive in this respect than a low-salt-diet or even antihyper-
tensive medication [9].
Weight-loss also induces a lowering of hyperlipopro-
teinemia with an increase of HDL-levels [10].
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Inaddition,themuscularmassoftheleftventricle,anoth-
errecognizedrisk-factor,decreasesbysuccessfulweight
reduction [11].
A drastic weight-lowering by gastric banding leads to an
improvement of pulmonary function [12]. In addition, a
strictcaloricrestraintwith a 14,5 % reductionin starting-
weight induced in 19 obese patients with asthma led to
significant improvements in pulmonary function, extent
of medication, subjective well-being and frequency of at-
tacks even after one year [13].
In315obesepatientswithBMIabove35,gastricbanding
ledtoaweightreductionof30kgonaverageandlowered
the percentage of "snorers" from 82 to 14 %, the fre-
quency of OSA (obstructive sleep-apnoea-syndrom) fell
from 33 to 2(!) % and instead of 39 % only 2 % claimed
afterwards that they did not sleep well [14].
During the SOS-study mentioned above, it could be
demonstrated that a weight-loss of 22 kg on average by
surgical intervention diminished the increase of intima-
media-diameter in the carotid bulbus by two/thirds to a
degree which can be observed in a control population
[15] of slimmer individuals.
Whilst urate-levels during fasting increase distinctly - es-
pecially if patients do not drink enough - due to a compe-
tition in excretion between uric acid and ketone-bodies
produced in large amounts during fasting, urate concen-
trationfallsconsiderablyafterlong-termweight-reduction
[16].
Eventheincreasedtotalleucocyte-countasanindication
of an impaired immunity-situation in obesity responds to
a weight-lowering [17].
It is a well known fact that successful weight-reduction
can normalize menstruation-disorders and impaired fer-
tility in obese women [18]. In our Optifast®-center, we
had to stop several weight-reduction-measures because
of a pregnancy which developed unexpectedly after a
long period of sterility [19].
Paralleltoweight-lowering,wecouldalsolargelynormalize
the parameters of neuroticism and extraversion which
show pathologic deviations in obesity [20].
It took a long time, until the hoped for improvement in
life-expectancybyweight-reductioncouldreallybeproven.
Numerousstudiesledtodivergingresults,mostlybecause
therewasnodifferentiationbetweenatherapeuticweight-
reductionandweight-lossbyseverediseases.Retrospect-
iveanalysishasdemonstratedthatfat-lossitselfimproves
life-expectancy, whilst pure weight loss may lead to its
decrease, as has been shown in two especially well con-
trolledcommunity-studies:TecumsehCommunityHealth
Study: 321 deaths in 1,890 participants after 16 years
observation [21] and the Framingham Heart Study: 507
deaths in 2,731 participants after 8 years [22]. This
probably explains the divergent findings and hypotheses
about the improvement in life-duration after weight loss.
Apart from first hints in the Build-Study 1979 [23], we
have now 3 studies which lend support to the hypothesis
that weight reduction does not only improve risk-factors,
but also prolongs life:
- In white US-women, observed during 12 years by the
AmericanCancerSociety,voluntaryweightlossesbetween
0,5 and 9 kg lowered total mortality by 20 % [24]. Car-
cinoma-mortalitywasreducedby37%,diabetes-mortality
by44%andcardio-vascularmortalityby35%.Thiseffect
wasespeciallyimpressiveinwomenwithanunfavourable
pre-investigation situation.
-InIndia,Singhetal.[25]reportedadiminishedmortality
after myocardial infarction in patients who liberally con-
sumed fruits and vegetables and this improvement was
especially pronounced after a weight-reduction by 10 %.
-Afterverticalgastroplasty,the10-years-mortalityreached
10 % in the non-operated control-group and only 3,7 %
in the extremely obese treated by surgical intervention
[26].
Reduction of the visceral fat depots seems to be the de-
cisivefactorfortheimprovementinlife-expectancy,whilst
pure weight-loss seems to have a rather life-shortening-
effect [21].
Finally, we should consider that our patients are (much)
moreimpressedandmotivated by otherfacts[27]: "I can
again go dancing at last and buy attractive clothing", "I
now can tie my shoes myself", or "my jogging partner
Bruno with slight overweight is glad because he beats
me again after losing 6 kg as he used to before".
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